Therapeutic targeting at genome mutations of liver cancer by the insertion of HSV1 thymidine kinase through Cas9-mediated editing. - Kader M; Sun W; Ren BG; Yu YP; Tao J; Foley LM; Liu S; Monga SP; Luo JH (Hepatology communications, 2024)